'Benghazi'-Like Hearing Unlikely For Califf, But Expect Questions
This article was originally published in Scrip
Executive Summary
Robert Califf, President Barack Obama's nominee to lead the FDA, is expected to have a fairly easy time of it when he goes before a Senate panel at a confirmation hearing on Nov. 17 – so much so that he's still planning to speak later that day at the annual Conference on Clinical Cancer Research hosted by the Friends of Cancer Research (FOCR) and the Brookings Institution.